VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

Bullboard Posts

Comment by OakTreeforest39on Nov 12, 2020 3:31pm

169 Views

Post# 31886759

RE:RE:RE:RE:RE:Timing is everything!

When I say it's just 7 millions market cap company, I mean you can just by 10000 shares and by the rest on the rise if you are still hesitating. You will still make a lot of money! Otherwise, you lose only 1k. And with such a small cap, you buy a bet in the management team! Nothing else! Cause a great product with a bad team is bad...Just check GA resume!

Bullboard Posts

E3 inches closer to Alberta's first lithium production plant